{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:furosemide",
  "owner": "cardio",
  "kind": "drug",
  "slug": "furosemide",
  "name": "Furosemide",
  "aliases": [
    "Lasix"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Furosemide, sold as Lasix, is a diuretic that works on the kidney, taken by mouth in the form read here. The US label read, for Lasix tablets, lists swelling from fluid build-up in people with congestive heart failure, cirrhosis of the liver and kidney disease including the nephrotic syndrome, in adults and children. It says the oral form may also be used in adults for high blood pressure, alone or with other blood pressure medicines.",
  "summary_technical": "RxNorm ingredient 4603; UNII 7LXU5N7ZO5. MeSH descriptor D005665 is Furosemide. Class: Loop Diuretic (FDA established pharmacologic class, RxClass). The label read is the Validus Pharmaceuticals LLC label for Lasix tablets, application NDA016273, effective 2025-09-30 in openFDA; the cluster that wrote the loop diuretic class page read the same label. Other furosemide products in openFDA, including the injection labels and the Lasix ONYU subcutaneous product, were not read. This page records label indications, the mechanism sentence and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": "2026-11-18",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "4603",
      "normalized_value": "4603",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "7LXU5N7ZO5",
      "normalized_value": "7LXU5N7ZO5",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D005665",
      "normalized_value": "D005665",
      "match": "exact",
      "version": "read 2026-11-18",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "kidneys"
      ],
      "condition-area": [
        "heart-failure",
        "hypertension",
        "kidney-connections"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": "The label says furosemide mainly inhibits the absorption of sodium and chloride in the kidney, including in the loop of Henle."
  },
  "content_digest": "7f147c8cd6a0a72821f9a0bca0d97fbc555914baa702999a9da85a39351ab4cf",
  "review": {
    "content_digest": "7f147c8cd6a0a72821f9a0bca0d97fbc555914baa702999a9da85a39351ab4cf",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-furosemide-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:furosemide",
      "category": "descriptive",
      "statement": "The US label of Lasix (furosemide tablets, Validus Pharmaceuticals LLC, application NDA016273; the version dated 2025-09-30 in openFDA) lists the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome, in adults and pediatric patients. It says oral Lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.",
      "context": {
        "id": "cardio:ctx-fda-lasix-label-us",
        "label": "Adults and pediatric patients with edema, and adults with hypertension, as described in the US label of a loop diuretic",
        "recipient": "mixed",
        "population": "Patients described in the indications section of the label: adults and pediatric patients with edema associated with congestive heart failure, cirrhosis of the liver or renal disease, and adults with hypertension.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Adults and pediatric patients for edema; adults for hypertension, as the label states",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adults and pediatric patients with edema associated with congestive heart failure, cirrhosis of the liver or renal disease",
            "Adults with hypertension"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Other furosemide labels, including injections, list different routes and uses. Contraindications, warnings, interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-18",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], INDICATIONS AND USAGE, Edema",
          "applicability_note": "Label passage quoted in the research quote table (LB-04, LB-05).",
          "snapshot": {
            "id": "cardio:openfda-label-lasix-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:37Z",
            "content_hash": "ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0",
            "source_effective_date": "2025-09-30",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-lasix",
            "source_type": "regulator",
            "title": "openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-lasix.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], INDICATIONS AND USAGE, Hypertension",
          "applicability_note": "Label passage quoted in the research quote table (LB-06).",
          "snapshot": {
            "id": "cardio:openfda-label-lasix-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:37Z",
            "content_hash": "ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0",
            "source_effective_date": "2025-09-30",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-lasix",
            "source_type": "regulator",
            "title": "openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-lasix.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20250930.",
          "snapshot": {
            "id": "cardio:openfda-label-lasix-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:37Z",
            "content_hash": "ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0",
            "source_effective_date": "2025-09-30",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-lasix",
            "source_type": "regulator",
            "title": "openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-lasix.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "b8aece849873a5e5fcf79aac83f213d387c8accf5d4b331a8806d544771ab0b4",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-furosemide-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Furosemide is a loop diuretic (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:loop-diuretics",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-4603-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists edema associated with congestive heart failure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-furosemide-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label says the oral form may be used for hypertension",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-furosemide-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "drugs/furosemide/",
  "context_path": "api/v1/context/cardio--furosemide.md"
}
